Microfluidics, lung surfactant, and respiratory disorders

Laboratory Medicine

Volumn 40, Issue 4, 2009, Pages 203-209

  Tavana, Hossein ^a   Huh, Dongeun ^a   Grotberg, James B ^a   Takayama, Shuichi ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE; LUNG SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY OBSTRUCTION; ASTHMA; CYSTIC FIBROSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; MICROFLUIDICS; NONHUMAN; RESPIRATORY TRACT DISEASE; REVIEW;

EID: 70349405090     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/LMJWE0WO65VFWPAS     Document Type: Review

References (45)

1. Levitzky MG. Pulmonary Physiology. 7 th ed., New York: McGraw-Hill; 2007:1-10.
2. West JB. Respiratory Physiology: The Essentials. 7th ed. Philadelphia: Lippincott Williams &Wilkins: 2005;93-120.
3. Macklem PT. The physiology of small airways. Am J Respir Crit Care Med. 1998;157:S181-S183.
4. Alonso C, Alig T, Yoon J, et al. More than a monolayer: Relating lung surfactant structure and mechanics to composition. Biophys J. 2004;87:4188-4202.
5. Notter RH. Lung Surfactant: Basic Science and Clinical Applications. Boca Raton, FL: CRC Press; 2000.
6. Gunther A, Siebert C, Schmidt R, et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med. 1996;153:176-184. (Pubitemid 26026846)
7. Gunasekara L, Schoel WM, Schürch S, et al. A comparative study of mechanisms of surfactant inhibition. Biochim Biophys Acta. 2008;1778:433-444.
8. Jain M, Sznajder JI. Bench to bed-side review: Distal airways in acute respiratory distress syndrome. Crit Care. 2007;11:206.
9. Hohlfeld JM. The role of surfactant in asthma. Respir Res. 2002;3:4.
10. Wright SM, Hockey PM, Enhorning G, et al. Altered airway surfactant phospholipid composition and reduced lung function in asthma. J Appl Physiol. 2000;89:1283-1292.
11. Baritussio A. Lung surfactant, asthma, and allergens: A story in evolution. Am J Respir Crit Care Med. 2004;169:550-551.
12. Hohlfeld JM, Schmiedl A, Erpenbeck VJ, et al. Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma. J Allergy Clin Immun. 2004;113:496-502.
13. Griese M, Birrer P, Demirsoy A. Pulmonary surfactant in cystic fibrosis. Eur Respir J. 1997;10:1983-1988.
14. Meyer KC, Sharma A, Brown R, et al. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis. Chest. 2000;118:164-174.
15. Pelosi P, Rocco PRM. Airway closure: The silent killer of peripheral airways. Crit Care. 2007;11:114.
16. Cassidy KJ, Halpern D, Ressler BG, et al. Surfactant effects in model airway closure experiments. J Appl Physiol. 1999;87:415-427.
17. Otis DR, Johnson M, Pedley TJ, et al. Role of pulmonary surfactant in airway closure: A computational study. J Appl Physiol. 1993;75:1323-1333.
18. Gaver III DP, Halpern D, Jensen OE. Surfactant and airway liquid flows. In: Molecular Mechanisms in Lung Surfactant (Dys)function. New York: Marcel Dekker; 2005.
19. Halpern D, Grotberg JB. Fluid-elastic instabilities of liquid-lined flexible tubes. J Fluid Mech. 1992;244:615-632.
20. Kraft M. The distal airways: Are they important in asthma? Eur Respir J. 1999;14:1403-1417.
21. Tulic MK, Christodoulopoulos P, Hamid Q. Small airway inflammation in asthma. Respir Res. 2001;2:333-339
22. King CG, Salome CM. Multimodality measurements of small airways disease. Eur Respir J. 2006;27:250-252.
23. Ingram RH Jr. Physiological assessment of inflammation in the peripheral lung of asthmatic patients. Lung. 1990;168:237-247.
24. Wagner EM, Bleecker ER, Permutt S, et al. Direct assessment of small airways reactivity in human subjects. Am J Respir Crit Care Med. 1998;157:447-452.
25. Wagner EM, Liu MC, Weinmann G, et al. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis. 1990;141:584-588.
26. Kuwano K, Bosken CH, Paré PD, et al. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1993;148:1220-1225.
27. Hamid QA. Peripheral inflammation is more important than central inflammation. Respir Med. 1997;91:11-12.
28. Bilek AM, Dee KC, Gaver DP III. Mechanisms of surface-tension-induced epithelial cell damage in a model of pulmonary airway reopening. J Appl Physiol. 2003;94:770-783.
29. Fujioka H, Takayama S, Grotberg JB. Unsteady propagation of a liquid plug in a liquid-lined straight tube. Phys Fluids. 2008;20:062104.
30. Ghadiali SN, Gaver DP III. An investigation of pulmonary surfactant physicochemical behavior under airway reopening conditions. J Appl Physiol. 2000;88:493-506.
31. Fujioka H, Takayama S, Grotberg JB. The steady propagation of a surfactant-laden liquid plug in a two-dimensional channel. Phys Fluids. 2005;17:082102.
32. Brown R, Wollcock AJ, Vincent NJ, et al. Physiological effects of experimental airway obstruction with beads. J Appl Physiol. 1969;27:328-335.
33. Hogg W, Brunton J, Kryger M, et al. Gas diffusion across collateral channels. J Appl Physiol. 1972;33:568-575.
34. Muscedere JG, Mullen JB, Gan K, et al. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit CareMed. 1994;149:1327-1334.
35. Taskar V, John J, Evander E, et al. Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion. Am J Respir Crit Care Med. 1997;155:313-320.
36. D'Angelo E, Pecchiari M, Baraggia P, et al. Low-volume ventilation causes peripheral airway injury and increased airway resistance in normal rabbits. J Appl Physiol. 2002;92:949-956.
37. Krug N, Rabe KF. Animal models for human asthma: The perspective of a clinician. Curr Drug Targets. 2008;9:438-442.
38. Zosky GR, Sly PD. Animal models of asthma. Clinic Exp Allergy. 2007;37:973-988.
39. Michel FB, Marty JP, Quet L, et al. Penetration of inhaled pollen into the respiratory tract. Am Rev Respir Dis. 1977;115:609-616.
40. van de Woestijne KP. Are the small airways really quiet? Eur J Respir Dis Suppl. 1982;121:19-25.
41. Kinsella M, Müller N L, Staples C, et al. Hyperinflation in asthma and emphysema. Assessment by pulmonary function testing and computed tomography. Chest. 1988;94: 286-289.
42. Sackner MA. Serendipity times two: Fiberoptic bronchoscopy becomes a medical procedure. Am J Respir Crit Care Med. 2002;166: 639-640.
43. Tavana H, ChungY-K, Kuo C-H, et al. Microfluidic systems for cellular applications. In: Biological Applications of Microfluidics. New York: Springer; 2008.
44. Huh D, Fujioka H, Tung, Y-C, et al. Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems. Proc Natl Acad Sci USA. 2007;104:18886-18891.
45. Duffy DC, McDonald JC, Schueller OJA, et al. Rapid prototyping of microfluidic systems in poly(dimethylsiloxane). Anal Chem. 1998;70:4974-4984.